Compugen is a drug and diagnostic discovery company, addressing important unmet therapeutic and diagnostic needs.
Compugen has raised €68M across 1 funding round, most recently a round in Mar 2020. Based in Tel Aviv, Israel; founded 1993; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-03-15 | Other | €68M |
| — |
| View deal → |
